 |
Highlights
Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design and trial endpoints.
UK sites added to the XanaCIDD trial of cognitive impairment associated with depression, due to report results mid-2024.
SYDNEY, Sept. 26, 2023 /PRNewswire/ --
XanaM...
Being an entrepreneur in any industry always comes with pressure from all corners. This includes decision-making, managing your employees, maintaining the business budget, etc. Hence, keeping track of your company’s progress wil...
After a tough period of border closures and restrictions, Australians are set to treat themselves this sales season, according to new research by Finder, Australia’s most visited comparison site. A nationally representative...
There are many ways to accept payments from customers and clients: cash, cards, buy now pay later, bank transfers and digital wallets. While some are more expensive than others, some can help take your business to the next level...